Literature DB >> 3814479

Lymphocytopenia as an independent predictor of early recurrence in breast cancer.

C W Pattison, K L Woods, J M Morrison.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3814479      PMCID： PMC2001556          DOI： 10.1038/bjc.1987.15

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

Review 1.  Adjuvant systemic therapy in breast cancer; a review.

Authors:  H T Mouridsen; T Palshof
Journal:  Eur J Cancer Clin Oncol       Date:  1983-12

2.  The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma.

Authors:  A E Papatestas; G J Lesnick; G Genkins; A H Aufses
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

3.  Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer.

Authors:  H E Ownby; L D Roi; R R Isenberg; M J Brennan
Journal:  Cancer       Date:  1983-07-01       Impact factor: 6.860

4.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

5.  Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.

Authors:  A Adler; J A Stein; S Ben-Efraim
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy.

Authors:  J Feehally; T J Beattie; P E Brenchley; B M Coupes; I B Houston; N P Mallick; R J Postlethwaite
Journal:  N Engl J Med       Date:  1984-02-16       Impact factor: 91.245

Review 7.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

8.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

9.  Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.

Authors:  H L Whitwell; H P Hughes; M Moore; A Ahmed
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640
  9 in total
  10 in total

1.  Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.

Authors:  Seyda Gündüz; Sema Sezgin Göksu; Deniz Arslan; Ali Murat Tatli; Mükremin Uysal; Umut Riza Gündüz; Mert Mahsuni Sevinç; Hasan Senol Coşkun; Hakan Bozcuk; Hasan Mutlu; Burhan Savas
Journal:  Mol Clin Oncol       Date:  2015-07-21

2.  Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.

Authors:  Yingchun Li; Chenyu Wang; Mengdan Xu; Cuicui Kong; Aibing Qu; Meng Zhang; Zhichao Zheng; Guirong Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-20       Impact factor: 4.553

3.  Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment.

Authors:  Concetta Elisa Onesti; Claire Josse; Aurélie Poncin; Pierre Frères; Christophe Poulet; Vincent Bours; Guy Jerusalem
Journal:  Oncotarget       Date:  2018-09-14

4.  Prognostic Value Of Preoperative Systemic Inflammatory Biomarkers In Patients With Gallbladder Cancer And The Establishment Of A Nomogram.

Authors:  Yan Deng; Feng Zhang; Xiao Yu; Cheng-Long Huo; Zhen-Gang Sun; Shuai Wang
Journal:  Cancer Manag Res       Date:  2019-10-21       Impact factor: 3.989

5.  Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer.

Authors:  Bader Alshamsan; Aisha Alshibany; Mahmoud A Elshenawy; Ahmed Badran; Tusneem Elhassan; Dahish Ajarim; Adher Alsayed; Kausar Suleman; Taher Al-Tweigeri
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

6.  Effects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial.

Authors:  John M Saxton; Emma J Scott; Amanda J Daley; M Woodroofe; Nanette Mutrie; Helen Crank; Hilary J Powers; Robert E Coleman
Journal:  Breast Cancer Res       Date:  2014-04-14       Impact factor: 6.466

Review 7.  The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis.

Authors:  Bajin Wei; Minya Yao; Chunyang Xing; Wei Wang; Jia Yao; Yun Hong; Yu Liu; Peifen Fu
Journal:  Onco Targets Ther       Date:  2016-09-08       Impact factor: 4.147

8.  Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse.

Authors:  Concetta Elisa Onesti; Claire Josse; Delphine Boulet; Jérôme Thiry; Barbara Beaumecker; Vincent Bours; Guy Jerusalem
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110

9.  Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.

Authors:  Anosheh Afghahi; Natasha Purington; Summer S Han; Manisha Desai; Emma Pierson; Maya B Mathur; Tina Seto; Caroline A Thompson; Joseph Rigdon; Melinda L Telli; Sunil S Badve; Christina N Curtis; Robert B West; Kathleen Horst; Scarlett L Gomez; James M Ford; George W Sledge; Allison W Kurian
Journal:  Clin Cancer Res       Date:  2018-03-26       Impact factor: 13.801

10.  Prognostic value of preoperative lymphocyte-to-monocyte ratio in gallbladder carcinoma patients and the establishment of a prognostic nomogram.

Authors:  Yan Deng; Ming-Fang Xu; Feng Zhang; Xiao Yu; Xue-Wen Zhang; Zhen-Gang Sun; Shuai Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.